Request Demo
Last update 23 Jan 2025
GF-CART01
Last update 23 Jan 2025
Overview
Basic Info
Drug Type CAR-T |
Synonyms- |
Target |
Mechanism CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), CD20 inhibitors(B-lymphocyte antigen CD20 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with GF-CART01NCT06703892
An Open-Label, Non-Randomized, Phase I, Prospective, Dose- Finding Study to Evaluate the Safety and Clinical Activity of GF- CART01 (CD20/19 CAR T Cell) in Subjects with Relapsed or Refractory B-Cell Hematological Malignancies
100 Clinical Results associated with GF-CART01
Login to view more data
100 Translational Medicine associated with GF-CART01
Login to view more data
100 Patents (Medical) associated with GF-CART01
Login to view more data
100 Deals associated with GF-CART01
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| B-Cell Malignant Neoplasm | Phase 1 | TW | 01 Mar 2025 | |
| Burkitt Lymphoma | Phase 1 | TW | 01 Mar 2025 | |
| Diffuse large B-cell lymphoma recurrent | Phase 1 | TW | 01 Mar 2025 | |
| Diffuse large B-cell lymphoma refractory | Phase 1 | TW | 01 Mar 2025 | |
| Follicular Lymphoma | Phase 1 | TW | 01 Mar 2025 | |
| High grade B-cell lymphoma | Phase 1 | TW | 01 Mar 2025 | |
| Lymphoplasmacytic Lymphoma | Phase 1 | TW | 01 Mar 2025 | |
| Marginal Zone B-Cell Lymphoma | Phase 1 | TW | 01 Mar 2025 | |
| Primary mediastinal large B-cell lymphoma recurrent | Phase 1 | TW | 01 Mar 2025 | |
| Primary mediastinal large B-cell lymphoma refractory | Phase 1 | TW | 01 Mar 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free